Table-II.
The comparison of the patients (MV support versus non-MV).
| MV(-) (n=58) | MV(+) (n=22) | p | |
|---|---|---|---|
| Age (years) | 31.0±14.4 | 36.0±16.1 | 0.208 |
| Female/male | 38/20 | 11/11 | 0.203 |
| Erythrocyte (10^6/μL.) | 4.7±0.5 | 4.4±0.7 | 0.111 |
| Hemoglobin (g/L) | 13.2±1.4 | 12.9±2.1 | 0.505 |
| Hematocrit (%) | 38.9±3.9 | 37.7±5.8 | 0.348 |
| MCV (fL) | 84.5±6.7 | 85.7±6.3 | 0.460 |
| White blood cell(x1.000/μl) | 13.1±5.1 | 12.5±4.1 | 0.607 |
| Platelet(103/ μL) | 261.3±78.8 | 252.9±81.3 | 0.678 |
| RDW(%) | 14.6±2.1 | 14.0±1.0 | 0.080 |
| BUN(mg/dl) | 11.4±3.9 | 14.2±8.5 | 0.144 |
| Fasting glucose(mg/dL) | 124.4±39.4 | 177.8±103.8 | 0.028* |
| Creatinine(mg/dL) | 0.59±0.16 | 0.75±0.29 | 0.018* |
| ALT(U/L) | 23.1±34.8 | 29.6±30.5 | 0.415 |
| AST(U/L) | 25.9±17.9 | 32.3±19.9 | 0.198 |
| PKE(KU/L) | 1.29±1.01 | 0.63±0.63 | 0.001* |
| GCS | 14.6±0.8 | 8.1±2.1 | 0.001* |
| TPE(n,%) | 0(0.0) | 10(45.5) | 0.001* |
| Duration of hospitalization(day) | 3.5±1.8 | 8.4±4.0 | 0.001* |
| Exitus (n, %) | 0(0.0) | 3(13.6) | 0.019* |
*
normal level for PChE is 4,9-11,9 KU/L